Not enough Pfizer vaccine doses? Blame the feds, not the company: reports
Just as thousands of Brits were lining up to get Pfizer’s mRNA COVID-19 vaccine yesterday, a troubling question emerged in…
Psychedelics Make a Comeback to Treat Mental Health Conditions
The FDA has approved only two products to treat TRD, and several companies are evaluating products with psychedelic properties as…
Combating Covid-19 Cold Chain Challenges
As the world continues to react to the impact of the global pandemic, by far the most significant challenges currently…
Practical Implications of Undertaking Clinical Trials during the COVID-19 Pandemic
Faced with the coronavirus pandemic, restrictions and ever-fluctuating situations have necessitated changes to ongoing andfuture clinical trials. Nariné Baririan at…
New FDA Guidance on Endpoints for Demonstrating Effectiveness of Drugs for Treatment of Opioid Use Disorder
Use and abuse of opioid products has increased alarmingly over the last 20 years, along with deaths due to overdose.…
The Importance of Global Collaboration for Successful Paediatric Development
The paediatric population which needs treatment is small compared to the adult population, hence the necessity for global drug development.…
Regenerative Medicine: Hype and Hope or Safety and Efficacy?
Regenerative medicine, and the underlying stem cell technology on which it is based, offers considerable hope to patients suffering from…
The Role of eConsent in Remote Trials
Today’s clinical trials demand flexible approaches and solutions. The drive to make trial participation more convenient and more inclusive for…
Clinical Development in Inflammatory Diseases: Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by an inflammatory polyarthritis that preferentiallyaffects the small joints. RA is…
For Paediatric Participants, Patient-centric Trials Must Be Family-centric
Clinical research in paediatric patients has long been the subject of ethical debate, focusing on topics as varied as a…